Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.45 |
| ▸ | RELA | Q04206 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5527507 | 0.78 | IDO1 (0.34) | IDO1ALOX15HSD17B10MAPK1TP53 | |
| SCHEMBL657866 | 0.78 | TYR (0.44) | HPGDMEN1KMT2ARAB9AMAPT | |
| SCHEMBL4156587 | 0.77 | ALDH1A1 (0.33) | IDO1ALOX15MAPK1HPGDSMN1; SMN2 | |
| SCHEMBL23923799 | 0.77 | APP (0.40) | IDO1ALOX15HSD17B10MAPK1TP53 | |
| SCHEMBL6664930 | 0.76 | CCNE2 (0.47) | IDO1ALOX15HSD17B10MAPK1TP53 | |
| SCHEMBL1857660 | 0.75 | IDO1 (0.53) | IDO1ALOX15HSD17B10HPGDSMN1; SMN2 | |
| SCHEMBL1176838 | 0.75 | METAP2 (0.30) | — | |
| SCHEMBL30497931 | 0.75 | IDO1 (0.53) | IDO1RAB9AALDH1A1DCUN1D1NPC1 | |
| SCHEMBL6693198 | 0.75 | DCUN1D1 (0.41) | IDO1ALOX15HSD17B10MAPK1HPGD | |
| SCHEMBL11624680 | 0.75 | IDO1 (0.53) | IDO1ALOX15HSD17B10MAPK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | claimed |
| EP-4622945-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2025-10-01 | — | — | EP | claimed |
| WO-2024110575-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2024-05-30 | — | — | WO | claimed |
| CN-117903054-A | Sulfur-containing o-hydroxyphenyl pyrazole compound, and preparation method and application thereof | 汉江师范学院 | 2024-04-19 | — | — | CN | claimed |
| WO-2022093770-A1 | COMBINATION THERAPY WITH PI3K-AKT-MTOR INHIBITORS AND FERROPTOSIS INDUCING AGENTS TO TREAT CANCER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-05-05 | — | — | WO | claimed |
| EP-2562294-B1 | PLATING BATH AND METHOD | ROHM & HAAS ELECT MAT (US) | 2019-09-25 | — | — | EP | claimed |
| EP-3370743-A1 | METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY | City of Hope (US) | 2018-09-12 | — | — | EP | claimed |
| WO-2017079528-A9 | METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY | CITY OF HOPE (US) | 2017-06-15 | — | — | WO | claimed |
| WO-2017079528-A1 | METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY | CITY OF HOPE (US) | 2017-05-11 | — | — | WO | claimed |
| CN-102953097-B | Electroplate liquid and electro-plating method | ROHM AND HAAS ELECTRONIC MATERIALS CO., LTD. (US) | 2016-01-13 | — | — | CN | claimed |
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | claimed |
| US-8747643-B2 | Plating bath and method | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-06-10 | — | — | US | claimed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | claimed |
| US-8470052-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2013-06-25 | — | — | US | claimed |
| EP-1926713-B1 | PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECH CORP (US) | 2013-04-10 | — | — | EP | claimed |
| US-20130048505-A1 | PLATING BATH AND METHOD | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-02-28 | — | — | US | claimed |
| US-20110136796-A1 | IDO Inhibitors | NEWLINK GENETICS (US) | 2011-06-09 | — | — | US | claimed |
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | disclosed |
| CN-1028227-C | Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same | ORTHO PHARMA CORP (US) | 1995-04-19 | — | — | CN | disclosed |
| CN-87103953-A | Pharmaceutically active 1, 5-diaryl-3-substituted pyrazoles and synthesis method thereof | — | 1987-12-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048505-A1 | PLATING BATH AND METHOD | EPHX1, CYP7B1, AOC3 | IDO1 3384/4885ALOX15 62/4885HSD17B10 640/4885 |
| US-20110136796-A1 | IDO Inhibitors | IDO1, IDO2, INMT | IDO1 1/4885ALOX15 707/4885HSD17B10 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.